The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche.
Saved in:
| Title: | The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. |
|---|---|
| Authors: | Gonzalez-Sanchez E; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.; Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain., Vaquero J; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.; Centro de Investigación del Cancer and Instituto de Biología Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, Salamanca, Spain., Caballero-Diaz D; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain., Grzelak J; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain., Fusté NP; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain., Bertran E; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain., Amengual J; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain., Garcia-Saez J; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.; Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Martín-Mur B; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Gut M; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Esteve-Codina A; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Alay A; Unit of Bioinformatics for Precision Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Spain., Coulouarn C; Inserm, Univ Rennes, OSS (Oncogenesis, Stress, Signaling) UMR_S 1242, Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France., Calero-Perez S; Biomedical Research Institute Sols-Morreale, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM); ISCIII, Madrid, Spain., Valdecantos P; Biomedical Research Institute Sols-Morreale, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM); ISCIII, Madrid, Spain., Valverde AM; Biomedical Research Institute Sols-Morreale, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC-UAM), Madrid, Spain.; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM); ISCIII, Madrid, Spain., Sánchez A; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.; Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Herrera B; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.; Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Fabregat I; Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.; Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain. |
| Source: | The Journal of pathology [J Pathol] 2024 Aug; Vol. 263 (4-5), pp. 482-495. Date of Electronic Publication: 2024 Jun 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-9896 |
|---|---|
| DOI: | 10.1002/path.6299 |
